Abstract: To provide a method of producing a processed cloth capable of forming various concave-convex patterns on a cloth material in a simple manner. A method of producing a processed cloth comprising the steps of: preparing a cloth; printing a first sizing agent containing a foaming agent on at least a portion of the cloth material; and pressing the printed cloth with a heated metal plate to foam the foaming agent. The method of producing a processed cloth may further include a step of printing a second sizing agent containing a coloring agent on the cloth material. The method of producing the processed cloth may further include a step of sublimation transfer to the cloth material.

Abstract: The invention describes a process for reworking of a crystallization product comprising drying and homogenization. The crystallization product is crystalline [5-(methylsulfonyl)-2-{[(2R)-1,1,1-trifluoropropan-2-yl]oxy}phenyl]{(1R,5R)-1-[5-(trifluoromethyl)-1,2-oxazol-3-yl]-3-azabicyclo[3.1.0]hex-3-yl}methanone. The product is dried in a tray dryer or in a pan dryer and subsequently homogenized.

Abstract: The present invention relates to compound III and its use for treatment and/or prevention of diseases of the schizophrenia spectrum and other psychotic disorders, first episodes of these diseases such as first episode of psychosis (FEP), relapses of these diseases such as reduction of relapse in patients with schizophrenia (REX). The invention also relates to polymorphs of compound III, and pharmaceutical compositions comprising compound III and/or its polymorphs.

Abstract: A process for the preparation of an oral disintegrating tablet comprising the antihypertensive telmisartan and the tablet obtained by the process.

Abstract: The present invention relates to compound III and its use for treatment and/or prevention of diseases of the schizophrenia spectrum and other psychotic disorders, first episodes of these diseases such as first episode of psychosis (FEP), relapses of these diseases such as reduction of relapse in patients with schizophrenia (REX). The invention also relates to polymorphs of compound III, and pharmaceutical compositions comprising compound III and/or its polymorphs.

Abstract: The present invention discloses a pharmaceutical tablet with a first layer comprising telmisartan, and a second layer comprising hydrochlorothiazide, amiodipine, mannitol, microcrystalline cellulose and corn starch, and a method of producing such a tablet.

Abstract: To provide a method of producing a processed cloth capable of forming various concave-convex patterns on a cloth material in a simple manner. A method of producing a processed cloth comprising the steps of: preparing a cloth; printing a first sizing agent containing a foaming agent on at least a portion of the cloth material; and pressing the printed cloth with a heated metal plate to foam the foaming agent. The method of producing a processed cloth may further include a step of printing a second sizing agent containing a coloring agent on the cloth material. The method of producing the processed cloth may further include a step of sublimation transfer to the cloth material.

Abstract: The present invention relates to compound III and its use for treatment and/or prevention of diseases of the schizophrenia spectrum and other psychotic disorders, first episodes of these diseases such as first episode of psychosis (FEP), relapses of these diseases such as reduction of relapse in patients with schizophrenia (REX). The invention also relates to polymorphs of compound III, and pharmaceutical compositions comprising compound III and/or its polymorphs.

Abstract: A process for the preparation of an immediate release tablet comprising the antihypertensive telmisartan and the tablet obtained by the process.

Abstract: A process for the preparation of an oral disintegrating tablet comprising the antihypertensive telmisartan and the tablet obtained by the process.

Abstract: A process for the preparation of an oral disintegrating tablet comprising the antihypertensive telmisartan and the tablet obtained by the process.

Abstract: A woven fabric to facilitate formation of embellishments such as pleats has a plurality of warp and weft yarns interlaced with each other, wherein some of the plurality of warp yarns 10 are strands of shrinkable warp yarn 21 that shrink in a lengthwise direction thereof more than the other warp yarns when subjected to a specific process, the shrinkable warp yarns 21 have, at least in one section in the lengthwise direction, a first leap portion 21J leaping over a first predetermined number of adjacent weft yarns 12, and a plurality of the first leap portions 21J are positioned in a first predetermined pattern. Shrinkable weft yarns 22 that shrink in a lengthwise direction thereof more than the other weft yarns when subjected to the specific process can be used in some of weft yarn 12.

Abstract: A process for the preparation of an oral disintegrating tablet comprising the antihypertensive telmisartan and the tablet obtained by the process.

Abstract: A pharmaceutical composition comprising 3 wt. % to 50 wt. % telmisartan dispersed in a dissolving matrix comprising: (a) a basic agent in a molar ratio of basic agent:telmisartan of 1:1 to 10:|1|; (b) about 1 wt. % to about 20 wt. % of a surfactant or emulsifier; (c) 25 wt. % to 70 wt. % of a water-soluble |diluent|; and (d) 0 wt. % to 20 wt. % of one or more additional excipients and/or |adjuvants|; wherein the sum of all components is 100%, methods of making such pharmaceutical compositions, and their use.

Abstract: The invention relates to a bilayer pharmaceutical tablet comprising a first layer containing 3 to 50 wt. % of telmisartan dispersed in a dissolving tablet matrix and a second layer containing a diuretic in a disintegrating tablet matrix as well as a processes for producing same.

Abstract: This image processing device for games is a device whereby a prescribed number of models (characters) are setup in virtual space, these models are controlled such that they move in prescribed directions in the virtual space, and images of this virtual space from a virtual viewpoint are displayed on means for display. In order to display the movement of the models that are arranged in virtual space more realistically, in one construction thereof, this device is provided with means for image processing that apply virtual centripetal force to the models. Furthermore, in order to display the movement of the models more realistically and to heighten the dramatic effect, in one construction thereof, this device is equipped with means for processing residual image presentation in order to represent the track of movement of a model as residual images.

Abstract: The present invention relates to a pharmaceutical fixed dose combination tablet comprising repaglinide and metformin. The present invention also provides a method of producing said tablet.

Abstract: The present invention relates to a pharmaceutical fixed dose combination tablet comprising repaglinide and metformin. The present invention also provides a method of producing said tablet.

Abstract: This image processing device for games is a device whereby a prescribed number of models (characters) are setup in virtual space, these models are controlled such that they move in prescribed directions in the virtual space, and images of this virtual space from a virtual viewpoint are displayed on means for display. In order to display the movement of the models that are arranged in virtual space more realistically, in one construction thereof, this device is provided with means for image processing that apply virtual centripetal force to the models. Furthermore, in order to display the movement of the models more realistically and to heighten the dramatic effect, in one construction thereof, this device is equipped with means for processing residual image presentation in order to represent the track of movement of a model as residual images.

Abstract: The invention relates to a bilayer pharmaceutical tablet comprising a first layer containing 3 to 50 wt. % of telmisartan dispersed in a dissolving tablet matrix and a second layer containing a diuretic in a disintegrating tablet matrix as well as a processes for producing same.